canceldeath

Research feed

Understand the finding first, then explore the evidence. Choose your reading level and sources independently.

Advanced research filters
Clear advanced filters

Dates show original publication, separately from when we added the story. Clinical trials lists registry activity separately. Check collection coverage.

  1. Trial registry · no verified findings· AgelessRx

    Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study (PEARL): A Prospective, Double-Blind, Placebo-Controlled Trial for Rapamycin in Healthy Individuals Assessing Safety and Efficacy in Reducing Aging Effects

    Published Jan 24, 2024Added 1moStart a discussionShare on XRapamycin

    Trial registry update: COMPLETED. No results reported in the supplied registry record.

    Evidence assessment pending · RCT

    Read the source · AgelessRx ↗
  2. Trial registry · no verified findings· Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    RCT of immunotherapy plus senolytics versus control before head and neck cancer surgery

    Published Sep 19, 2024Added 1moStart a discussionShare on XSenolytics

    A Phase II randomised controlled trial evaluated tislelizumab (anti-PD-1 antibody) combined with dasatinib and quercetin (senolytics) as neoadjuvant therapy before surgery in patients with head and neck squamous cell carcinoma. The trial assessed efficacy and safety of this combined immunotherapy-senolytic approach.

    Evidence assessment pending · OTHER

    Read the source · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ↗
  3. Trial registry · no verified findings· The University of Texas Health Science Center at San Antonio

    An Innovative Proof-of-concept Approach to Identify Age-modulating Drugs Capable of Reversing Inflammation and Re-setting the Epigenetic Clock (Topical-RAPA)

    Published Jul 19, 2023Added 1moStart a discussionShare on XRapamycin

    Trial registry update: COMPLETED. Results are posted in the registry; assessment pending.

    Evidence assessment pending · RCT

    Read the source · The University of Texas Health Science Center at San Antonio ↗
  4. Trial registry · no verified findings· Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    Randomized Controlled Trial of Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome

    Published Sep 28, 2021Added 1moStart a discussionShare on XMetforminExercise

    Trial registry update: COMPLETED. No results reported in the supplied registry record.

    Evidence assessment pending · RCT

    Read the source · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ↗
  5. Trial registry · no verified findings· The University of Texas Health Science Center at San Antonio

    Pilot Study to Investigate the Safety and Feasibility of Senolytic Therapy to Modulate Progression of Alzheimer's Disease (SToMP-AD)

    Published Mar 6, 2023Added 1moStart a discussionShare on XSenolytics

    Trial registry update: COMPLETED. Results are posted in the registry; assessment pending.

    Evidence assessment pending · CASE REPORT

    Read the source · The University of Texas Health Science Center at San Antonio ↗
  6. Trial registry · no verified findings· Wake Forest University Health Sciences

    Senolytic drugs dasatinib plus quercetin reduced pro-inflammatory cells in small open-label IPF pilot study.

    Published May 12, 2020Added 1moStart a discussionShare on XSenolytics

    Open-label pilot study in patients with idiopathic pulmonary fibrosis examining intermittent oral dosing of dasatinib plus quercetin over 3 weeks. The intervention aimed to reduce pro-inflammatory cells and cellular senescence markers. The study assessed safety, tolerability, and effects on inflammatory biomarkers, with hypothesized preservation of functional outcomes.

    Evidence assessment pending · RCT

    Read the source · Wake Forest University Health Sciences ↗
  7. Trial registry · no verified findings· The University of Texas Health Science Center at San Antonio

    Effect of Mammalian Target of Rapamycin Inhibition and Other Metabolism Modulating Interventions on the Elderly: Immune, Cognitive, and Functional Consequences

    Published Dec 4, 2018Added 1moStart a discussionShare on XRapamycin

    Trial registry update: COMPLETED. Results are posted in the registry; assessment pending.

    Evidence assessment pending · RCT

    Read the source · The University of Texas Health Science Center at San Antonio ↗